(2026). LINC01128 Affects Triple-Negative Breast Cancer Progression Through Targeting miR-32-5p. Breast Cancer : Targets and Therapy.
Successfully copied to clipboard
Copying to clipboard failed
Chicago Style (17th ed.) Citation
"LINC01128 Affects Triple-Negative Breast Cancer Progression Through Targeting MiR-32-5p."
Breast Cancer : Targets and Therapy 2026.
Successfully copied to clipboard
Copying to clipboard failed
MLA (9th ed.) Citation
"LINC01128 Affects Triple-Negative Breast Cancer Progression Through Targeting MiR-32-5p."
Breast Cancer : Targets and Therapy, 2026.
Successfully copied to clipboard
Copying to clipboard failed
Warning: These citations may not always be 100% accurate.